Cargando…
Cell-Based Models of ‘Cytokine Release Syndrome’ Endorse CD40L and Granulocyte–Macrophage Colony-Stimulating Factor Knockout in Chimeric Antigen Receptor T Cells as Mitigation Strategy
While chimeric antigen receptor (CAR) T cell therapy has shown promising outcomes among patients with hematologic malignancies, it has also been associated with undesirable side-effects such as cytokine release syndrome (CRS). CRS is triggered by CAR T-cell-based activation of monocytes, which are s...
Autores principales: | Dibas, Ala, Rhiel, Manuel, Patel, Vidisha Bhavesh, Andrieux, Geoffroy, Boerries, Melanie, Cornu, Tatjana I., Alzubi, Jamal, Cathomen, Toni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649043/ https://www.ncbi.nlm.nih.gov/pubmed/37947658 http://dx.doi.org/10.3390/cells12212581 |
Ejemplares similares
-
T-CAST: An optimized CAST-Seq pipeline for TALEN confirms superior safety and efficacy of obligate-heterodimeric scaffolds
por: Rhiel, Manuel, et al.
Publicado: (2023) -
A novel Cas9 fusion protein promotes targeted genome editing with reduced mutational burden in primary human cells
por: Carusillo, Antonio, et al.
Publicado: (2023) -
Allele-Specific Disruption of a Common STAT3 Autosomal Dominant Allele Is Not Sufficient to Restore Downstream Signaling in Patient-Derived T Cells
por: König, Saskia, et al.
Publicado: (2022) -
Automated generation of gene-edited CAR T cells at clinical scale
por: Alzubi, Jamal, et al.
Publicado: (2020) -
TALE-PvuII Fusion Proteins – Novel Tools for Gene Targeting
por: Yanik, Mert, et al.
Publicado: (2013)